Here’s Why M&A Is Heating Up in Nuclear Infrastructure Sector
Tower operator SBA exploring sale.
This article is for subscribers only.
Hi, it’s Veena Ali-Khan in New York. Nuclear has been creeping back into dealmakers’ conversations for a while now and it just got louder. Also today, Neurocrine is buying Soleno Therapeutics for $2.9 billion.
Today’s top stories